Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
49 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
75 people
Portfolia
San MateoSeed–Late Stage
58 people
RA Capital
BostonSeed–Late Stage
29 people
ARCH Venture Partners
ChicagoSeed–Growth$50K – $250M
43 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Future Planet Capital
LondonSeed–Late Stage
34 people
Elaia
ParisSeed–Growth$108K – $1.6M
51 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
76 people
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
29 people
Innovestor Ventures
HelsinkiPre-Seed–Growth$270K – $3.2M
29 people
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
28 people
Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
78 people
B Capital Group
Manhattan BeachSeed–Late Stage$100K – $60M
38 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
25 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
48 people
Cota Capital
San FranciscoPre-Seed–Series C
28 people
Cambridge Innovation Capital
CambridgeSeed–Late Stage$127K – $12.7M
60 people
Abstract
San FranciscoPre-Seed–Late Stage$250K – $750K
7 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
74 people
Summit Partners
BostonSeries B–Late Stage$10M – $500M
33 people
Anzu Partners
BillericaPre-Seed–Growth
57 people
Stifel Venture Banking
St. LouisSeed–Late Stage
75 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.